Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Aeolus selects AEOL-11207 as first development candidate

June 22, 2006

GDNF gene therapy is neuroprotective in Huntington's disease / News in Context

June 22, 2006

Novel agents for treating neurological disorders disclosed in recent patent literature

June 21, 2006

Recent Janssen and Zambon patents report novel analgesic agents

June 21, 2006

Cognition improvement by novel alpha7 nAChR partial agonist in rats

June 21, 2006

Clazosentan reduces occurrence of cerebral vasospasm in study

June 21, 2006

Oxybate improves fibromyalgia symptoms

June 21, 2006

Neurodex NDA review period extended

June 21, 2006

PharmaFrontiers changes name to Opexa Therapeutics

June 21, 2006

Synera topical anesthetic patch now available

June 20, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...